Switch to:
More From Other Websites
Sanofi : ENGAGE Randomized Clinical Trial Evaluating Cerdelga® (eliglustat) for Treatment-Naïve... Mar 06 2015
Sanofi : Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases Mar 06 2015
Sanofi : Sanofi Appoints Olivier Brandicourt as Chief Executive Officer Mar 06 2015
Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo® Mar 06 2015
Toujeo® Receives Positive Opinion from the European Regulatory Authorities Mar 06 2015
Top FDA Official Says Orexigen Study Result 'Unreliable,' 'Misleading' Mar 05 2015
Kidney treatment developer Tricida raises $30M in Series B Mar 05 2015
On the move: Life science hires and job transitions Mar 05 2015
Regulators Want Drug Companies to Be Honest About FDA Mar 04 2015
Johnson & Johnson's Zytiga May Get a Boost Mar 03 2015
Fighting dengue fever with genetically-modified mosquito ... Mar 03 2015
Goldman Downgrades MannKind To Sell, Should You Follow Their Lead? Mar 03 2015
Why MannKind Could Lose Half Its Value Mar 03 2015
NOTICE TO SANOFI EMPLOYEES: Zamansky LLC Investigates Sanofi’s U. S. Group Savings Plan For... Mar 03 2015
If You 'Want To Make A Good Drug Great' Cost Must Be Factored In Mar 03 2015
MannKind Rating, Price Target Are Cut by Goldman on Slow Afrezza Launch Mar 03 2015
Looking for European Dividends? Say Oui to the France ETF Mar 02 2015
MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter Mar 02 2015
What structural reforms are required by different countries? Feb 27 2015
Merrimack Pharmaceuticals Q4 Loss Narrower Than Expected - Analyst Blog Feb 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK